Middeldorp S - Search Results

1

Barco S, Nijkeuter M, Middeldorp S. Barco S, et al. Among authors: middeldorp s. Semin Thromb Hemost. 2013 Jul;39(5):549-58. doi: 10.1055/s-0033-1343893. Epub 2013 Apr 30. Semin Thromb Hemost. 2013. PMID: 23633191 Review.

2

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 1998 Jan 1;128(1):15-20. doi: 10.7326/0003-4819-128-1-199801010-00003. Ann Intern Med. 1998. PMID: 9424976

3

Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.

Middeldorp S, van der Meer J. Middeldorp S, et al. Semin Thromb Hemost. 1998;24(4):363-6. doi: 10.1055/s-2007-996024. Semin Thromb Hemost. 1998. PMID: 9763353 Review.

4

Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.

Franco RF, Middeldorp S, Meinardi JR, van Pampus EC, Reitsma PH. Franco RF, et al. Among authors: middeldorp s. Br J Haematol. 2000 Oct;111(1):118-21. doi: 10.1046/j.1365-2141.2000.02338.x. Br J Haematol. 2000. PMID: 11091190 Free article.

5

The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

Middeldorp S, Libourel EJ, Hamulyák K, Van der Meer J, Büller HR. Middeldorp S, et al. Br J Haematol. 2001 May;113(2):553-5. doi: 10.1046/j.1365-2141.2001.02766.x. Br J Haematol. 2001. PMID: 11380431 Free article.

6

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 2001 Sep 4;135(5):322-7. doi: 10.7326/0003-4819-135-5-200109040-00008. Ann Intern Med. 2001. PMID: 11529695

7

Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.

Bank I, Scavenius MP, Büller HR, Middeldorp S. Bank I, et al. Among authors: middeldorp s. Thromb Res. 2004;113(1):7-12. doi: 10.1016/j.thromres.2004.02.002. Thromb Res. 2004. PMID: 15081560 Clinical Trial.

8

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR. Bank I, et al. Among authors: middeldorp s. Arch Intern Med. 2004 Sep 27;164(17):1932-7. doi: 10.1001/archinte.164.17.1932. Arch Intern Med. 2004. PMID: 15451770

9

Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis.

Bank I, Tick LW, Hutten BA, Kramer MH, Middeldorp S, Büller HR. Bank I, et al. Among authors: middeldorp s. Pathophysiol Haemost Thromb. 2003 Jul-2004 Aug;33(4):192-6. doi: 10.1159/000081507. Pathophysiol Haemost Thromb. 2003. PMID: 15583448

10

Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.

Locadia M, Bossuyt PM, Stalmeier PF, Sprangers MA, van Dongen CJ, Middeldorp S, Bank I, van der Meer J, Hamulyák K, Prins MH. Locadia M, et al. Among authors: middeldorp s. Thromb Haemost. 2004 Dec;92(6):1336-41. doi: 10.1160/TH04-02-0075. Thromb Haemost. 2004. PMID: 15583742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters